Natixis Sarepta Therapeutics, Inc. Transaction History

Natixis

$17.6 Billion
Q3 2024

A detailed history of Natixis transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Natixis holds 10,119 shares of SRPT stock, worth $1.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

10,119

Previous 466 2071.46%

Holding current value

$1.1 Million

Previous $73,000 1630.14%

% of portfolio

0.01%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$124.33 - $156.75 $1.2 Million - $1.51 Million	9,653 Added 2071.46%	10,119 $1.26 Million
Q2 2024 Aug 13, 2024	SELL	$113.33 - $163.85 $14,619 - $21,136	-129 Reduced 21.68%	466 $73,000
Q1 2024 May 13, 2024	BUY	$93.7 - $141.53 $55,751 - $84,210	595 New	595 $77,000
Q1 2023 May 12, 2023	SELL	$117.53 - $155.99 $12.4 Million - $16.5 Million	-105,550 Reduced 98.37%	1,750 $241,000
Q4 2022 Feb 24, 2023	BUY	$100.86 - $132.13 $5.41 Million - $7.09 Million	53,650 Added 100.0%	107,300 $13.9 Million
Q4 2022 Feb 13, 2023	SELL	$100.86 - $132.13 $8.46 Million - $11.1 Million	-83,900 Reduced 61.0%	53,650 $6.95 Million
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $3.11 Million - $4.9 Million	-41,100 Reduced 23.01%	137,550 $15.2 Million
Q2 2022 Aug 12, 2022	BUY	$62.69 - $88.44 $2.74 Million - $3.87 Million	43,750 Added 32.43%	178,650 $13.4 Million
Q1 2022 May 13, 2022	SELL	$63.15 - $90.42 $6.47 Million - $9.27 Million	-102,500 Reduced 43.18%	134,900 $10.5 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $18.3 Million - $23.6 Million	237,400 New	237,400 $21.4 Million
Q2 2021 Aug 13, 2021	SELL	$69.38 - $86.75 $380,479 - $475,737	-5,484 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $11.6 Million - $27.2 Million	-160,931 Reduced 96.7%	5,484 $409,000
Q4 2020 Feb 12, 2021	BUY	$125.56 - $178.74 $20.9 Million - $29.7 Million	166,415 New	166,415 $28.4 Million
Q1 2019 May 15, 2019	SELL	$106.67 - $151.68 $4.25 Million - $6.04 Million	-39,805 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$97.32 - $148.76 $2.56 Million - $3.91 Million	26,254 Added 193.74%	39,805 $4.34 Million
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $1.06 Million - $1.49 Million	9,197 Added 211.23%	13,551 $2.19 Million
Q2 2018 Aug 14, 2018	SELL	$71.74 - $153.69 $233,728 - $500,722	-3,258 Reduced 42.8%	4,354 $576,000
Q1 2018 May 15, 2018	SELL	$54.02 - $82.27 $321,310 - $489,341	-5,948 Reduced 43.86%	7,612 $564,000
Q4 2017 Feb 14, 2018	BUY	$47.64 - $56.75 $645,998 - $769,530	13,560	13,560 $754,000

Others Institutions Holding SRPT

# of Institutions

528

Shares Held

84M

Call Options Held

1.99M

Put Options Held

1.36M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.55B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Account